TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
4 hedge funds and large institutions have $42K invested in Therapix Biosciences Ltd. in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$39K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
$1K |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $39K | +$1.91K | +470 | +5% |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | -$10.3K | -2,427 | -84% |
|
|
IA
3
IFP Advisors
Tampa,
Florida
| $1K | +$526 | +100 | +111% |
|
|
4
Acadian Asset Management
Boston,
Massachusetts
| – | -$23K | -4,100 | Closed |
|